EU Bureaucracy

Business

Therapeutics Sector Shows Resilience in Q3: United Therapeutics Lags as Halozyme and Biogen Outperform

A mixed third-quarter earnings season for therapeutics stocks reveals divergent paths, with United Therapeutics missing estimates while peers like Halozyme and Biogen post strong beats. Sector-wide revenue growth and positive stock reactions suggest underlying investor confidence despite regulatory and pricing headwinds.

Jan 30, 2026

Business

PTC Therapeutics Gains Analyst Favor: Barclays Upgrade Fuels Valuation Debate Amid Rare Disease Focus

Barclays' upgrade of PTC Therapeutics to Overweight has spotlighted the biotech firm's valuation, with shares showing strong momentum but questions lingering over its path to profitability and reliance on a narrow drug portfolio.

Jan 30, 2026

Business

Occidental Petroleum's Rocky Road: Analysts Remain Cautious Despite Recent Oil-Price Tailwinds

While rising crude prices have lifted Occidental Petroleum's stock recently, a mixed earnings performance and a predominantly 'Hold' rating from Wall Street signal lingering skepticism about its near-term trajectory.

Jan 30, 2026

Business

Amneal Pharmaceuticals: A Deep Value Play After Stellar Run?

Amneal Pharmaceuticals' shares have surged over 64% in the past year, prompting investors to question if the rally still has room to run. A closer look at valuation metrics suggests the generic drugmaker may still be trading at a significant discount to its intrinsic value.

Jan 30, 2026

Business

Corcept Therapeutics Stock Plummets as FDA Reveals It Warned Company Against Drug Submission

Shares of Corcept Therapeutics plunged 16% after a corrected FDA letter disclosed the agency had repeatedly cautioned the company against filing its application for a Cushing's syndrome drug, which was later rejected over efficacy and safety concerns.

Jan 30, 2026

World

U.S. and EU Escalate Pressure on Iran with Sanctions Targeting Interior Minister Over Protest Crackdown

The United States, in coordination with European allies, has imposed new sanctions on Iran's Interior Minister and other officials, accusing them of orchestrating a violent suppression of nationwide protests. The measures target assets and travel, reflecting a widening international response to Tehran's handling of domestic unrest.

Jan 30, 2026

Business

Bitmine's Leadership Shakeup and Massive Ethereum Bet Raise Investor Concerns

Bitmine Immersion Technologies faces heightened scrutiny following the sudden departure of its president and a strategic pivot that has seen it amass over 3.5% of all Ethereum. Analysts question the dual risks of management instability and extreme asset concentration as the stock shows recent volatility.

Jan 30, 2026

World

EU Commissioner Expresses Dismay Over Minneapolis Violence, Urges Transatlantic Unity Amid Strained T.S. Relations

European Commission Vice President Teresa Ribera voices profound shock at the fatal shootings of two protesters in Minneapolis, contrasting with the EU's official cautious stance. Her remarks come as transatlantic tensions simmer over U.S. immigration policies and recent geopolitical threats.

Jan 30, 2026

World

Exclusive: Europe's $500 Billion Crisis Fund Eyed for Defense Loans Amid Rising Geopolitical Tensions

The head of the European Stability Mechanism has told Reuters the bloc's 430-billion-euro emergency fund could be repurposed to provide defense loans to member states, signaling a strategic shift as Europe seeks to bolster its military autonomy.

Jan 30, 2026

World

Denmark Defies European Court, Unveils Sweeping Deportation Overhaul

Denmark's government announced a bold legislative package aimed at expanding deportations and tightening immigration controls, setting the stage for a potential clash with the European Court of Human Rights.

Jan 30, 2026

Business

BofA Lifts Greif Price Target to $75, Maintains Neutral Stance Amid Packaging Sector Review

Bank of America has increased its price target for industrial packaging firm Greif (GEF) by $1 to $75, while reiterating a Neutral rating. The adjustment follows the bank's broader reassessment of the packaging sector after recent quarterly earnings calls.

Jan 30, 2026

Business

LifeSci Capital Boosts Price Target on Olema Pharmaceuticals, Citing Promising Breast Cancer Drug Pipeline

LifeSci Capital reaffirms its Buy rating on Olema Pharmaceuticals (OLMA) and raises its price target to $45, following bullish analyst sentiment on the company's lead drug candidate, Palazestrant, for ER+/HER2- breast cancer.

Jan 30, 2026

Business

Thomson Reuters Doubles Down on AI as CIBC Maintains Bullish Stance Despite Price Target Trim

CIBC reaffirms its Outperform rating on Thomson Reuters (TRI) as the information giant accelerates its strategic push into AI-driven compliance and legal tools, launching new products in the US and UK markets.

Jan 30, 2026

World

Rare earth power: can Europe ever escape its dependency on China?

Europe relies on China for the rare earth elements essential in transition technologies, but it's making a late bid to end dependency.

Jan 30, 2026

Business

Deutsche Bank Posts Record Profit Amid Broad-Based Growth, Shadowed by Fresh Legal Scrutiny

Deutsche Bank's 2025 net profit nearly doubled to €7.1bn, fueled by revenue gains and cost cuts across all divisions, even as German prosecutors launch a money-laundering investigation linked to the lender.

Jan 30, 2026

World

Eurozone Economy Defies Trade Headwinds, Posts Stronger-Than-Expected 2025 Growth

The Eurozone economy expanded by 1.5% in 2025, outpacing forecasts despite ongoing trade tensions with the US, as a recovery in Germany and robust growth in Spain helped offset a slowdown in France.

Jan 30, 2026

Business

Medtronic Doubles Down on Heart Rhythm and Outpatient Care with European Approval and Expanded Partnership

Medtronic secures a key European regulatory nod for its latest pulsed field ablation catheter while deepening its collaboration with Mindray, signaling a strategic push into high-growth areas of cardiac care and ambulatory surgery.

Jan 30, 2026

Business

Strategic Shift: Australian Laser Weapons Pioneer EOS Poised for European Relocation Amid Defence Spending Surge

Electro Optic Systems (EOS), the Australian firm behind a landmark high-energy laser contract, is planning a strategic move of its headquarters and listing to Europe within the year, its CEO reveals, aiming to embed itself at the heart of the continent's urgent defence modernisation drive.

Jan 30, 2026

World

Iran Threatens to Label EU Armed Forces as Terrorists in Retaliatory Move

Iran has announced plans to designate the armed forces of European Union member states as terrorist organizations, a direct response to the EU's blacklisting of the Islamic Revolutionary Guard Corps. The escalation marks a new low in diplomatic relations and raises fears of further regional instability.

Jan 30, 2026

Business

UK Industry Faces Compliance Cliff Edge as EU Digital Product Passport Looms

New research reveals a stark preparedness gap among UK manufacturers and wholesalers for the impending EU Digital Product Passport (DPP), with nearly half unaware of the regulation that could bar non-compliant goods from the single market.

Jan 30, 2026